Westbury, NY – Apr. 6, 2020 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the opening of its new blood donor center on the Tufts University campus in Medford, MA to support academic and pharmaceutical researchers involved in COVID-19, cell and gene therapy research.
“BioIVT wants to play a leading role in supporting COVID-19 research efforts and blood donations are a vital resource for the research and development of new therapies, vaccines, and diagnostics. We have many years’ experience developing blood products, including…
tranScrip (www.transcrip-partners.com) is delighted to be supporting Synairgen with their first patient dosing in a trial of SNG001 in COVID-19.
tranScrip's support in this important endeavour is a continuation of being at the heart of the development of SNG001 (inhaled formulation of interferon-beta-1a) for the last 12 years.
Dr Marcin Mankowski, Deputy Managing Partner and Head of tranScrip’s ID Team, commented: “tranScrip has collaborated with Synairgen for many years, supporting the development of SNG001 to address an important medical need in the treatment of viral exacerbations of…
Cambridge, UK - 6 April 2020 - Healx, the AI-powered, patient-inspired biotech specialising in rare diseases, today announces it is using its AI platform to develop drug combinations from approved drugs to contribute towards global efforts to find treatments for COVID-19. This focus on combination therapies, where two or more drugs simultaneously target different aspects of the disease pathology, has the potential to ensure a more effective treatment.
Combination therapies are particularly difficult to discover. To uncover potential combination treatments for COVID-19 requires detailed…
Cambridge, UK – 2 April 2020 – Scientists on Standby has been rapidly conceptualised and launched in response to the COVID-19 crisis and in anticipation of the increasing pressure on UK diagnostic testing laboratories and facilities in the coming weeks and months. The portal enables scientists with relevant skills and experience to volunteer their time, expertise and support for COVID-19 screening and testing.
Scientists on Standby, developed by specialist Life Science marketing agency BioStrata, is looking for qualified scientists specialising in reverse transcription-Polymerase Chain…
Cambridge, UK, 03 April 2020: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the addition of an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services.
Primary human cells, which are cells that are freshly isolated from donors, are known to be difficult to study in the lab. However, working with these cells brings scientists one step closer to healthy or diseased micro-environments, enabling them…
I’ve worked from home for 9 years, starting off as Head of R&D for a virtual biotech, then as CEO of Agility Health Tech. For the last few years, I’ve hardly been at home, I was mostly on site with clients, talking at events or meeting with potential new clients. Until two weeks ago…
In one of my early days of working from home, my wife came home from work and I greeted her with, “I saw a bee!”. Now, in my defence, it was December so seeing a bee was a surprise and, therefore, noteworthy. My wife’s response was, “You haven’t spoken to anyone today, have you?”. She was bang on. I hadn’t…
Following on from the success of our first webinar on EU GMP Annex 1 - Implications for Sterile Products Manufacture, RSSL are gearing up for the second installment of their three-part webinar series on manufacturing sterile pharmaceuticals.
The second webinar, to be held 6 May, will be on the topic of Reviewing Sterile Products - Examining the Factors Required for Release and will again be hosted by Dr Tim Sandle.
This webinar is ideal for anyone looking to gain an insight into the critical microbiological quality attributes required for the manufacture of sterile products, while gaining an…
Join a COVID-19 marketing mastermind group to get a fresh perspective and new ideas during these challenging times.
The COVID-19 pandemic is creating unique challenges for life science marketing and comms professionals. To overcome them, we’ll need to work together to share experiences and brainstorm solutions. To help, One Nucleus and long term member, BioStrata, are collaborating to deliver Marketing Masterminds – a free platform created by the BioStrata team for industry peers to share their ideas, insights and support during the coronavirus pandemic.
Find out more and join today: …
AMSBIO report on a world first clinical study of iPSC-derived corneal epithelial cells by Professor Ryuhei Hayashi and co-workers from the Graduate School of Medicine, Osaka University, Japan using StemFit Basic03 clinical grade stem cell culture medium and iMatrix-511 recombinant laminin E8 fragments.In this ground-breaking work, corneal epithelial sheets from HLA-homozygous iPS cells were produced using and transplanted into patients with corneal epithelial stem cell deficiency. The clinical study was approved by the Japanese…
Cambridge, UK, and Budapest, Hungary, 31 March 2020: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, and Pharmahungary Group, a preclinical and clinical R&D company, today announced positive early-stage results for a novel micro-RNA therapeutic for ischemic heart diseases. RNA oligonucleotides, custom-manufactured by Horizon at its Boulder, Colorado site (formerly Dharmacon, Inc.), were used in successful studies that have paved the way for in vivo proof-of-…